Vascular Endothelium as a Target of Beraprost Sodium and Fenofibrate for Antiatherosclerotic Therapy in Type 2 Diabetes Mellitus

References

• BeckmanJACreagerMALibbyPDiabetes and atherosclerosis: epidemiology, pathophysiology, and managementJAMA200228725708112020339
   PubMed Web of Science ®Google Scholar
• BevilacquaMPNelsonRMMannoriGEndothelial-leukocyte adhesion molecules in human diseaseAnnu Rev Med199445361787515220
   PubMed Web of Science ®Google Scholar
• BonoraEMuggeoMPostprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidenceDiabetologia20014421071411793012
   PubMed Web of Science ®Google Scholar
• CapellWHDeSouzaCAPoirierPShort-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemiaArterioscler Thromb Vasc Biol2003233071312588776
   PubMed Web of Science ®Google Scholar
• Caulin-GlaserTWatsonCAPardiREffects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expressionJ Clin Invest19969836428690801
   PubMed Web of Science ®Google Scholar
• CelermajerDSSorensenKEGeorgakopoulosDCigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adultsCirculation1993882149558222109
   PubMed Web of Science ®Google Scholar
• CelermajerDSSorensenKEBullCEndothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interactionJ Am Coll Cardiol1994241468747930277
   PubMed Web of Science ®Google Scholar
• CelermajerDSSorensenKESpiegelhalterDJAging is associated with endothelial dysfunction in healthy men years before the age-related decline in womenJ Am Coll Cardiol19942447168034885
   PubMed Web of Science ®Google Scholar
• CerielloAQuagliaroLCatoneBRole of hyperglycemia in nitrotyrosine postprandial generationDiabetes Care20022514394312145247
   PubMed Web of Science ®Google Scholar
• ColhounHMBetteridgeDJDurringtonPNPrimary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialLancet20043646859615325833
   PubMed Web of Science ®Google Scholar
• CollinsRArmitageJParishSHeart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialLancet200336120051612814710
   PubMed Web of Science ®Google Scholar
• CreagerMACookeJPMendelsohnMEImpaired vasodilation of forearm resistance vessels in hypercholesterolemic humansJ Clin Invest199086228342195060
   PubMed Web of Science ®Google Scholar
• CybulskyMIGimbroneMAJrEndothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesisScience1991251788911990440
   PubMed Web of Science ®Google Scholar
• Diabetes Atherosclerosis Intervention Study InvestigatorsEffect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised studyLancet20013579051011289345
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research GroupThe effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitusN Engl J Med1993329977868366922
   PubMed Web of Science ®Google Scholar
• EmpenKFrostRJGeissHCDifferential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trialCardiovasc Diabetol200321714662011
   PubMed Web of Science ®Google Scholar
• EspositoKGiuglianoDNappoFCampanian Postprandial Hyperglycemia Study GroupRegression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitusCirculation20041102141915197140
   PubMed Web of Science ®Google Scholar
• EspositoKNappoFMarfellaRInflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stressCirculation200210620677212379575
   PubMed Web of Science ®Google Scholar
• GaedePVedelPLarsenNMultifactorial intervention and cardiovascular disease in patients with type 2 diabetesN Engl J Med20033483839312556541
   PubMed Web of Science ®Google Scholar
• GargAStatins for all patients with type 2 diabetes: not so soonLancet2004364641215325810
   PubMed Web of Science ®Google Scholar
• GilleJPaxtonLLLawleyTJRetinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cellsJ Clin Invest1997994925009022083
   PubMed Web of Science ®Google Scholar
• GiuglianoDMarfellaRCoppolaLVascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemiaCirculation1997951783909107164
   PubMed Web of Science ®Google Scholar
• GoyaKKitamuraTInabaMRisk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complicationsMetabolism2003521302614564682
   PubMed Web of Science ®Google Scholar
• GoyaKOtsukiMXuXEffects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitusMetabolism200352192812601631
   PubMed Web of Science ®Google Scholar
• GoyaKSumitaniSXuXPeroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cellsArterioscler Thromb Vasc Biol2004246586314751809
   PubMed Web of Science ®Google Scholar
• HanefeldMCagatayMPetrowitschTAcarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studiesEur Heart J200425101614683737
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983511755629635947
   PubMed Web of Science ®Google Scholar
• HashimotoKKasayamaSYamamotoHStrong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertensionDiabet Med200421581515154943
   PubMed Web of Science ®Google Scholar
• JagerAvan HinsberghVWKostensePJIncreased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn studyDiabetes2000494859110868972
   PubMed Web of Science ®Google Scholar
• JoannidesRHaefeliWELinderLNitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivoCirculation1995911314197867167
   PubMed Web of Science ®Google Scholar
• JohnstoneMTCreagerSJScalesKMImpaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitusCirculation1993882510168080489
   PubMed Web of Science ®Google Scholar
• KeatingGMOrmrodDMicronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemiaDrugs20026219094412215067
   PubMed Web of Science ®Google Scholar
• KleinRHyperglycemia and microvascular and macrovascular disease in diabetesDiabetes Care199518258687729308
   PubMed Web of Science ®Google Scholar
• MarfellaREspositoKGiuntaRCirculating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemiaCirculation200010122475110811590
   PubMed Web of Science ®Google Scholar
• MarxNSukhovaGKCollinsTPPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cellsCirculation19999931253110377075
   PubMed Web of Science ®Google Scholar
• MeekingDRCummingsMHThorneSEndothelial dysfunction in type 2 diabetic subjects with and without microalbuminuriaDiabet Med199916841710547211
   PubMed Web of Science ®Google Scholar
• O'BrienKDAllenMDMcDonaldTOVascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosisJ Clin Invest199392945517688768
   PubMed Web of Science ®Google Scholar
• OtsukiMHashimotoKMorimotoYCirculating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patientsDiabetes19974620961019392502
   PubMed Web of Science ®Google Scholar
• OtsukiMSaitoHXuXProgesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cellsArterioscler Thromb Vasc Biol200121243811156860
   PubMed Web of Science ®Google Scholar
• PanzaJAQuyyumiAABrushJEJrAbnormal endothelium-dependent vascular relaxation in patients with essential hypertensionN Engl J Med19903232272355955
   PubMed Web of Science ®Google Scholar
• PaolissoGBarbagalloMPetrellaGEffects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patientsAtherosclerosis2000150121710781642
   PubMed Web of Science ®Google Scholar
• PlayfordDAWattsGFBestJDEffect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitusAm J Cardiol2002901254712450611
   PubMed Web of Science ®Google Scholar
• RossRAtherosclerosis – an inflammatory diseaseN Engl J Med1999340115269887164
   PubMed Web of Science ®Google Scholar
• SeverPSDahlofBPoulterNRPrevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial – Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialLancet200336111495812686036
   PubMed Web of Science ®Google Scholar
• SheuWHJuangBLChenYTEndothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemiaDiabetes Care1999221224510389000
   PubMed Web of Science ®Google Scholar
• SimonciniTDe CaterinaRGenazzaniARSelective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cellsJ Clin Endocrinol Metab1999848151810022460
   PubMed Web of Science ®Google Scholar
• SimonciniTMaffeiSBastaGEstrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanismsCirc Res200087192510884367
   PubMed Web of Science ®Google Scholar
• StamlerJVaccaroONeatonJDDiabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention TrialDiabetes Care199316434448432214
   PubMed Web of Science ®Google Scholar
• StehouwerCDNautaJJZeldenrustGCUrinary albumin excretion, cardiovascular disease, and endothelial dysfunction in noninsulin-dependent diabetes mellitusLancet1992340319231353802
   PubMed Web of Science ®Google Scholar
• TanKCChowWSTamSCAtorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitusJ Clin Endocrinol Metab200287563811836286
   PubMed Web of Science ®Google Scholar
• [UKPDS] UK Prospective Diabetes Study GroupIntensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet1998a35283753
   PubMed Web of Science ®Google Scholar
• [UKPDS] UK Prospective Diabetes Study GroupTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ1998b31770313
   PubMedGoogle Scholar
• VakkilainenJSteinerGAnsquerJCRelationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS)Circulation20031071733712665498
   PubMed Web of Science ®Google Scholar
• van EttenRWde KoningEJHoningMLIntensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetesArterioscler Thromb Vasc Biol20022279980412006393
   PubMed Web of Science ®Google Scholar
• WagenknechtLEZaccaroDEspelandMADiabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis studyArterioscler Thromb Vasc Biol20032310354112702517
   PubMed Web of Science ®Google Scholar
• WilliamsSBCuscoJARoddyMAImpaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJ Am Coll Cardiol199627567748606266
   PubMed Web of Science ®Google Scholar
• WolfrumSJensenKSLiaoJKEndothelium-dependent effects of statinsArterioscler Thromb Vasc Biol2003237293612615672
   PubMed Web of Science ®Google Scholar
• WooKSChookPLolinYIHyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humansCirculation199796254249355891
   PubMed Web of Science ®Google Scholar
• WoodmanRJChewGTWattsGFMechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapyDrugs200565317415610050
   PubMed Web of Science ®Google Scholar
• XuXOtsukiMSaitoHPPARα and GR differentially downregulate the expression of nuclear factor-κB-responsive genes in vascular endothelial cellsEndocrinology20011423332911459775
   PubMed Web of Science ®Google Scholar